Selleck Chemicals - Model A2926 -Lonigutamab (Anti-IGF1R / CD221)

Lonigutamab (hz208F2-4) is a humanized monoclonal antibody against the insulin-like growth factor-1 receptor (IGF-1R) with the potential to treat thyroid eye disease (TED). MW: 146.26 KD.